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We compared human and bovine isolates of Salmonel-
la enterica using antimicrobial-drug resistance proﬁ  les and 
pulsed-ﬁ  eld gel electrophoresis. From 2000 through 2006, 
we observed an increase in a novel multidrug-resistant 
clone of S. Typhimurium with no recognized phage type. 
This clone may represent an emerging epidemic strain in 
the Paciﬁ  c Northwest.
N
ontyphoidal salmonellosis has been characterized by a 
pattern of dissemination of clonal Salmonella enteri-
ca. The most well-known example of this was S. enterica 
serovar Typhimurium deﬁ  nitive phage type 104 (DT104), a 
clone that emerged and disseminated globally in the 1990s 
(1). Other examples of epidemic clones include Salmonella 
serovar Wien, which spread from North Africa through Eu-
rope in the 1970s; S. Typhimurium phage type 10 (DT10), 
which disseminated across Canada in the 1970s; and oth-
er phage types of S. Typhimurium associated with cattle 
that disseminated widely in Europe during the 1980s (2). 
More recently, multidrug-resistant (MDR) S. Agona was 
disseminated in poultry in Belgium; MDR S. Paratyphi B 
dT+ in Germany, Belgium, and the Netherlands; and MDR 
S. Newport that harbors the plasmid-mediated AmpC re-
sistance in the United States (3). Epidemic clones may 
remain largely restricted to the animal reservoir for years 
before their incidence rises among human infections: S. Ty-
phimurium phage type 204c disseminated throughout the 
United Kingdom in cattle from 1980 through 1984, but its 
proportion among human S. Typhimurium infections was 
not high during that period (4). Some epidemic clones, for 
example DT10 and DT104, expanded in the absence of a 
speciﬁ  c resistance advantage (1). The mechanisms under-
lying emergence, dissemination, and subsequent decline of 
novel Salmonella clones are unknown, although some re-
searchers have hypothesized that ﬁ  tness-associated genetic 
factors may allow more efﬁ  cient dissemination in speciﬁ  c 
hosts and environments (5) and that acquisition of these ﬁ  t-
ness genes may be phage mediated (6).
One approach to understanding clonal replacement 
events is to conduct prospective surveillance of Salmonella 
infections in animal and human hosts. We initiated such 
a study to compare human- and animal-origin Salmonella 
strains by serovar, antimicrobial drug resistance pattern, 
and pulsed-ﬁ  eld gel electrophoresis (PFGE).
The Study
In Washington, all clinical laboratories and health-
care providers are required to submit Salmonella isolates 
to the Washington State Department of Health Public 
Health Laboratory (PHL) for serotyping and surveillance 
(Washington Administrative Code 246–101–201). The 
PHL is a participant in PulseNet, a national surveillance 
system established in 1996 that allows state and local 
public health epidemiologists to compare PFGE proﬁ  les 
of Salmonella strains from all US regions (7). All human 
isolates are compared at the PHL by using a standard 
PFGE PulseNet protocol (8). Beginning in January 2004, 
all human-origin isolates were obtained from the PHL by 
the Washington State University Zoonosis Research Unit 
in Pullman. Animal-origin isolates were obtained from 
the Washington Animal Disease Diagnostic Laboratory 
in Pullman, the Washington Avian Health Laboratory in 
Puyallup, and a private veterinary diagnostic laboratory. 
In addition to isolates originating from clinical veterinary 
submissions, we obtained isolates from a research study 
targeting Salmonella occurrence on dairy farms in Wash-
ington (D. Hancock et al., unpub. data). All isolates were 
tested for resistance to a panel of antimicrobial drugs with 
a standard disk-diffusion method (9) according to Clinical 
and Laboratory Standards Institute guidelines (10) (Table 
1). Isolates collected from January 1, 2000, through April 
2005 were tested for susceptibility to a panel of antimicro-
bial drugs (Table 1). Animal-origin isolates that matched 
human-origin isolates by serotype and resistance pattern 
were further compared by using a standard PFGE proto-
col (8). Cluster analysis using the unweighted pair group 
method with arithmetic mean analysis (UPGMA) of Dice 
similarity coefﬁ  cients based on PFGE banding patterns 
was computed in Bionumerics (Applied Maths, Sint-Mar-
tens-Latem, Belgium). To limit the effect of nonindepen-
dence among isolates, only the ﬁ  rst in each serotype and 
resistance pattern group within each herd and calendar 
year was included in the analysis. Statistical signiﬁ  cance 
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testing of the change in proportions was conducted in Epi-
Info version 6.0 with χ2 for linear trend (11).
We observed an increase in bovine-origin S. Ty-
phimurium isolates that were represented by 2 highly simi-
lar PFGE patterns, identiﬁ  ed as Washington State PulseNet 
types TYP035 and TYP187 (Table 2). They were clearly 
distinguishable from phage type DT104 strains isolated 
during the same time frame (online Appendix Figure, avail-
able from www.cdc.gov/EID/content/13/10/1583-appG.
htm). To determine whether these XbaI PFGE types were 
clonal, we characterized 60 S. Typhimurium isolates, in-
cluding 32 TYP035-TYP187 isolates from bovines and 19 
TYP035-TYP187 isolates from humans, by PFGE follow-
ing digestion of DNA by SpeI. SpeI patterns within each 
XbaI type showed only minor banding variations. Thirteen 
isolates that were XbaI-TYP035 had SpeI patterns indistin-
guishable from those of XbaI-TYP187 isolates. In the clus-
ter analysis of SpeI patterns, the TYP035 and TYP187 iso-
lates’ XbaI patterns were at least 90.1% similar compared 
to an overall 83.7% similarity for all S. Typhimurium iso-
lates in the analysis. Characterization of isolates within the 
XbaI PFGE type TYP035 also included plasmid proﬁ  les of 
38 isolates with published plasmid-proﬁ  ling methods (12). 
Isolates were selected for plasmid proﬁ  ling to maximize 
the diversity of resistance patterns, geographic origin, and 
year of isolation. Plasmid sizes were estimated relative to a 
BAC-Tracker Supercoiled DNA ladder (EPICENTRE Bio-
technologies, Madison, WI, USA). Fifteen of the 38 tested 
isolates harbored a single ≈120-kb plasmid. The remainder 
had variable plasmid proﬁ  les, but the plasmid proﬁ  ling data 
did not correlate with resistance phenotype or SpeI-banding 
variations (data not shown). Similar results were obtained 
with phage typing of a convenience sample of 31 isolates 
by Raﬁ  q Ahmed at the National Microbiology Laboratory, 
Winnipeg, Manitoba, Canada. All 31 TYP35 isolates were 
phage-type untypable with the standard Colindale panel of 
phages, although an additional set of phages were able to 
discriminate among some of them (R. Ahmed, pers. com-
mun.). The resulting categories of untypable phages (UT2, 
UT5, UT7, and UT8) were also not consistent with either 
plasmid proﬁ  le or resistance phenotypes (data not shown).
The proportion of all bovine independent S. Typhimuri-
um isolates in the TYP035–TYP187 clade increased sig-
niﬁ  cantly from 2000 to 2006 in Washington (χ2 for linear 
trend, p<0.01). The proportion also increased signiﬁ  cantly 
among human S. Typhimurium isolates during the same 
period (χ2 for linear trend, p<0.01) (Table 2). Expansion of 
TYP035 apparently occurred in the bovine population of 
the Paciﬁ  c Northwest before its increase among human iso-
lates because in 2000 it represented over one quarter of all 
bovine S. Typhimurium, but it was uncommon among hu-
man-source S. Typhimurium before 2002 to 2003 (Table 1). 
Similarly, TYP187 was detected in bovine isolates 2 years 
before its detection in human isolates. Resistance character-
istics varied among TYP035 and TYP187 isolates. Before 
2003, the predominant resistance pattern among TYP035 
isolates was the AKSSuT phenotype; after 2002, isolates 
were distributed more widely among several resistance pat-
1584  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 10, October 2007
Table 1. Trends in resistance of bovine-origin Salmonella Typhimurium PFGE types TYP035 and TYP187* 
Resistance characteristics† 2001 2002 2003 2004 2005 2006
TYP035
 ASu  111
ACaz 1
AKSuT 1 1
 AKSSuT  771414
ACKSSuT 1 1
AKSSuTCaz 3
AKSxtSSuT  1
ACKSSuTCaz 2 2
ACKSxtSSuT  1
AKSuTCaz 1
AKSSuTCaz 11
ACKSSuTCaz 21
 A C K S x t S S u T C a z   1164
AGKSxtSSuTCaz  1
Total 8 10 5 17 12 8
TYP187
ACSSuTCaz 1
AKSSuTCaz 11 2
AKSuTCaz 1
Total 12 1 2
*PFGE, pulsed-field gel electrophoresis. 
†A, ampicillin; Su, triple-sulfa; Caz, ceftazidime; K, kanamycin; T, tetracycline; S, streptomycin; C, chloramphenicol; Sxt, trimethoprim-sulfamethoxazole; 
G, gentamicin. In April 2005 nitrofurantoin, trimethoprim, and ciprofloxacin were dropped from the panel, and amoxicillin-clavulanic acid, nalidixic acid, 
and ceftazidime-clavulanic acid were added. S. Typhimurium, United States
terns (Table 1). The predominant resistance pattern among 
isolates of TYP187 was AKSSuTCaz (Table 1).
Conclusions
The strain type reported here may be an emerging epi-
demic clone of MDR Salmonella with the potential to ex-
pand further. Since 2001, TYP035 has been infrequently 
reported in the National PulseNet Database, and most spo-
radic cases were from Washington. The TYP187 proﬁ  le has 
never been reported outside of Washington. Comparison 
of PFGE patterns between Northwest and New York State 
S. Typhimurium isolates at the Cornell University Zoono-
sis Research Unit showed no occurrences of TYP035 or 
TYP187 among 23 bovine and 29 human S. Typhimurium 
isolates from the same period. These comparisons with iso-
lates from other parts of the United States suggest that the 
emergence of the TYP035/ TYP187 clade is currently fo-
cused in the Paciﬁ  c Northwest region but has the potential 
to become more widespread. In 2006, the Massachusetts 
Department of Public Health investigated an outbreak of 
salmonellosis associated with owl pellets among elemen-
tary school students (46 primary cases, 12 secondary cases) 
(13). This outbreak was caused by TYP035 S. Typhimuri-
um, and the supplier of the owl pellets was located in a 
rural county in south-central Washington. This outbreak 
illustrates that epidemic clones may disseminate widely 
by means of unpredictable vehicles and that nonfoodborne 
transmission can have a major public health impact. 
The TYP035/TYP187 clade ﬁ  rst increased in the ani-
mal reservoir, followed by spillover into the human popula-
tion, consistent with its being an emergent clone. Whether 
or not this strain will continue to expand, further character-
ization of this PFGE type and continued surveillance will 
be important steps for improving our understanding of epi-
demic Salmonella clones (3,5). 
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